New York: Novavax, Inc, a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, on Tuesday announced that it has been selected to participa ...
New York: The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans, accor ...
New York/IBNS: Moderna, Inc. a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for pa ...
Washington: The United States is planning to issue a warning that hackers tied to the Chinese government are attempting to steal information from researchers working to develop a coronavi ...
- 91 countries now offer COVID-19 vaccinations to refugees, says UNHCR
- Bangladesh: Authorities clear homegrown Bangavax coronavirus vaccine for clinical trial with conditions
- COVID-19 cases drop for seventh week, but deaths fall less slowly: WHO
- Two doses of COVID-19 vaccines are highly effective against hospitalisation from Delta variant: PHE
- WHO warns of ‘two-track pandemic’ as cases decline but vaccine inequity persists
